CoChat

Lower risks of cirrhosis and hepatocellular carcinoma with GLP‐1RAs in type 2 diabetes: A nationwide cohort study using target trial emulation framework

Yang, Chun‐Ting, Yao, Wen‐Yu, Yang, Chen‐Yi, Peng, Zi‐Yang, Ou, Huang‐Tz, Kuo, Shihchen · 2024 · Journal of Internal Medicine
Cited by 42

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Background: To assess the association of cirrhosis and hepatocellular carcinoma (HCC) with the use of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) versus long‐acting insulins (LAIs), which are the two commonly prescribed injectable glucose‐lowering agents (GLAs) for patients with type 2 diabetes (T2D) after the failure of multiple oral GLAs. Methods: We emulated a target trial using the nationwide data of a Taiwanese cohort with T2D. Incident new users of GLP‐1RAs and LAIs during 2013–2018 were identified, and propensity score (PS) matching was applied to ensure between‐group comparability in baseline patient characteristics. The primary outcome was the composite liver disease including cirrhosis or HCC. Each patient was followed until the occurrence of a study outcome, death, or the end of 2019, whichever came first. Subdistribution hazard models were employed to assess the treatment‐outcome association. Sensitivity (e.g., stabilized inverse probability of treatment weighting analysis, time‐dependent analysis), E‐value, and negative control outcome analyses were performed to examine the robustness of study findings. Results: We included 7171 PS‐matched pairs of GLP‐1RA and LAI users with no significant between‐group differences at baseline. Compared with LAIs, the use of GLP‐1RAs was associated with significantly reduced risks of composite liver disease (subdistribution hazard ratio [95% confidence interval]: 0.56 [0.42–0.76]), cirrhosis (0.59 [0.43–0.81]), and HCC (0.47 [0.24–0.93]). Results were consistent across sensitivity analyses and among patients with different baseline characteristics. Conclusion: Among T2D patients who require injectable GLAs, the use of GLP‐1RAs versus LAIs was associated with lower risks of cirrhosis and HCC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/joim.13751

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Yang, C., Yao, W., Yang, C., Peng, Z., Ou, H., & Kuo, S.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2023-11-22
Volume
295
Issue
3
Pages
357-368
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W4388952380
Cited by
42
References
15
FWCI
6.95
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.